{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:30:44Z","timestamp":1792290644893,"version":"4.4.0"},"reference-count":193,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Hepatocellular carcinoma (HCC) is a leading cause of global cancer-related mortality worldwide. Increasing evidence indicates that epigenetic mechanisms, which are potentially reversible and modifiable by environmental and nutritional factors, play a key role in hepatocarcinogenesis. Histone deacetylases (HDACs) are fundamental epigenetic modulators that regulate chromatin dynamics and ultimately gene transcription with important pathophysiological implications and promising therapeutic perspectives. The role of HDACs is gaining interest for the understanding of HCC development mechanisms and for the potential therapeutic implications of their natural and synthetic inhibitors. This review provides an overview on HDACs classification and their peculiar expression patterns in HCC, with a focus on zinc-dependent histone deacetylases (HDACs). HDAC inhibitors (HDACis), both synthetic and natural-derived compounds, are also discussed for their emerging effects in optimizing the anticancer efficacy of the current therapeutic strategies. Novel dietary-derived and bioactive compounds-based interventions are discussed in the context of HCC management as promising nutri-epigenetic avenues. Targeting HDACs bears a significant therapeutic potential for HCC management while further confirmatory clinical investigation is warranted.<\/jats:p>","DOI":"10.3390\/cells14171337","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T12:25:57Z","timestamp":1756470357000},"page":"1337","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Epigenetic Regulation Through Histone Deacetylation: Implications and Therapeutic Potential in Hepatocellular Carcinoma"],"prefix":"10.3390","volume":"14","author":[{"given":"Khulah","family":"Sadia","sequence":"first","affiliation":[{"name":"Department of Medicine, Section of Internal Medicine, University of Verona, Piazzale L.A. Scuro, 37134 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4650-0823","authenticated-orcid":false,"given":"Annalisa","family":"Castagna","sequence":"additional","affiliation":[{"name":"Department of Medicine, Section of Internal Medicine, University of Verona, Piazzale L.A. Scuro, 37134 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1259-497X","authenticated-orcid":false,"given":"Silvia","family":"Udali","sequence":"additional","affiliation":[{"name":"Department of Medicine, Section of Internal Medicine, University of Verona, Piazzale L.A. Scuro, 37134 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Ambrosani","sequence":"additional","affiliation":[{"name":"Department of Medicine, Section of Internal Medicine, University of Verona, Piazzale L.A. Scuro, 37134 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3679-4458","authenticated-orcid":false,"given":"Patrizia","family":"Pattini","sequence":"additional","affiliation":[{"name":"Department of Medicine, Section of Internal Medicine, University of Verona, Piazzale L.A. Scuro, 37134 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruggero","family":"Beri","sequence":"additional","affiliation":[{"name":"Department of Medicine, Section of Internal Medicine, University of Verona, Piazzale L.A. Scuro, 37134 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4747-4655","authenticated-orcid":false,"given":"Giuseppe","family":"Argentino","sequence":"additional","affiliation":[{"name":"Department of Medicine, Section of Internal Medicine, University of Verona, Piazzale L.A. Scuro, 37134 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Masutti","sequence":"additional","affiliation":[{"name":"Department of Medicine, Section of Internal Medicine, University of Verona, Piazzale L.A. Scuro, 37134 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Moruzzi","sequence":"additional","affiliation":[{"name":"Department of Medicine, Section of Internal Medicine, University of Verona, Piazzale L.A. Scuro, 37134 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9606-6711","authenticated-orcid":false,"given":"Simonetta","family":"Friso","sequence":"additional","affiliation":[{"name":"Department of Medicine, Section of Internal Medicine, University of Verona, Piazzale L.A. Scuro, 37134 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3945\/an.110.1004","article-title":"Epigenetics: A New Bridge between Nutrition and Health","volume":"1","author":"Choi","year":"2010","journal-title":"Adv. Nutr."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1161\/CIRCULATIONAHA.110.956839","article-title":"Epigenetic Modifications: Basic Mechanisms and Role in Cardiovascular Disease","volume":"123","author":"Handy","year":"2011","journal-title":"Circulation"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ymeth.2020.06.022","article-title":"Modern Epigenetics Methods in Biological Research","volume":"187","author":"Li","year":"2021","journal-title":"Methods"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/hep.27823","article-title":"Global DNA Methylation and Hydroxymethylation Differ in Hepatocellular Carcinoma and Cholangiocarcinoma and Relate to Survival Rate","volume":"62","author":"Udali","year":"2015","journal-title":"Hepatology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13148-015-0077-1","article-title":"DNA Methylation and Gene Expression Profiles Show Novel Regulatory Pathways in Hepatocellular Carcinoma","volume":"7","author":"Udali","year":"2015","journal-title":"Clin. Epigenetics"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Udali, S., De Santis, D., Ruzzenente, A., Moruzzi, S., Mazzi, F., Beschin, G., Tammen, S.A., Campagnaro, T., Pattini, P., and Olivieri, O. (2018). DNA Methylation and Hydroxymethylation in Primary Colon Cancer and Synchronous Hepatic Metastasis. Front. Genet., 8.","DOI":"10.3389\/fgene.2017.00229"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.trsl.2014.06.007","article-title":"Epigenetics and Arterial Hypertension: The Challenge of Emerging Evidence","volume":"165","author":"Friso","year":"2015","journal-title":"Transl. Res."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Moruzzi, S., Guarini, P., Udali, S., Ruzzenente, A., Guglielmi, A., Conci, S., Pattini, P., Martinelli, N., Olivieri, O., and Tammen, S.A. (2017). One-Carbon Genetic Variants and the Role of MTHFD1 1958G>A in Liver and Colon Cancer Risk According to Global DNA Methylation. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0185792"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/978-94-007-2199-9_14","article-title":"Vitamin B6 and Cardiovascular Disease","volume":"56","author":"Friso","year":"2012","journal-title":"Subcell. Biochem."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Moruzzi, S., Udali, S., Ruzzenente, A., Guglielmi, A., Guarini, P., Martinelli, N., Conci, S., Mazzi, F., Pattini, P., and Tammen, S.A. (2016). The RFC1 80G>A, among Common One-Carbon Polymorphisms, Relates to Survival Rate According to DNA Global Methylation in Primary Liver Cancers. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0167534"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"7543","DOI":"10.1007\/s10653-023-01749-8","article-title":"Environment Factors, DNA Methylation, and Cancer","volume":"45","author":"Liu","year":"2023","journal-title":"Environ. Geochem. Health"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.tig.2021.05.002","article-title":"Navigating the DNA Methylation Landscape of Cancer","volume":"37","author":"Nishiyama","year":"2021","journal-title":"Trends Genet."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1038\/s41588-022-01173-1","article-title":"RNA m6A Regulates Transcription via DNA Demethylation and Chromatin Accessibility","volume":"54","author":"Deng","year":"2022","journal-title":"Nat. Genet."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1038\/s41467-024-47314-4","article-title":"Non-Canonical Functions of UHRF1 Maintain DNA Methylation Homeostasis in Cancer Cells","volume":"15","author":"Yamaguchi","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"148387","DOI":"10.1016\/j.gene.2024.148387","article-title":"miRNA-27a-3p Is Involved in the Plasticity of Differentiated Hepatocytes","volume":"913","author":"Salerno","year":"2024","journal-title":"Gene"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e12870","DOI":"10.1111\/eci.12870","article-title":"Hepcidin and DNA Promoter Methylation in Hepatocellular Carcinoma","volume":"48","author":"Udali","year":"2018","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1124\/dmd.124.001665","article-title":"Epigenetic Activation of Cytochrome P450 1A2 Sensitizes Hepatocellular Carcinoma Cells to Sorafenib","volume":"52","author":"Zhang","year":"2024","journal-title":"Drug Metab. Dispos."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.canlet.2013.07.022","article-title":"Histone Deacetylase 3 Participates in Self-Renewal of Liver Cancer Stem Cells through Histone Modification","volume":"339","author":"Liu","year":"2013","journal-title":"Cancer Lett."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Liu, K.-Y., Wang, L.-T., and Hsu, S.-H. (2018). Modification of Epigenetic Histone Acetylation in Hepatocellular Carcinoma. Cancers, 10.","DOI":"10.3390\/cancers10010008"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Seo, Y., Kim, D.K., Park, J., Park, S.J., Park, J.J., Cheon, J.H., and Kim, T.I. (2024). A Comprehensive Understanding of Post-Translational Modification of Sox2 via Acetylation and O-GlcNAcylation in Colorectal Cancer. Cancers, 16.","DOI":"10.3390\/cancers16051035"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Xu, X., Ding, Y., Jin, J., Xu, C., Hu, W., Wu, S., Ding, G., Cheng, R., Cao, L., and Jia, S. (2023). Post-Translational Modification of CDK1-STAT3 Signaling by Fisetin Suppresses Pancreatic Cancer Stem Cell Properties. Cell Biosci., 13.","DOI":"10.1186\/s13578-023-01118-z"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"El Omari, N., Bakrim, S., Khalid, A., Abdalla, A.N., Almalki, W.H., Lee, L.-H., Ardianto, C., Ming, L.C., and Bouyahya, A. (2023). Molecular Mechanisms Underlying the Clinical Efficacy of Panobinostat Involve Stochasticity of Epigenetic Signaling, Sensitization to Anticancer Drugs, and Induction of Cellular Cell Death Related to Cellular Stresses. Biomed. Pharmacother., 164.","DOI":"10.1016\/j.biopha.2023.114886"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"118513","DOI":"10.1016\/j.lfs.2020.118513","article-title":"PI3K\/AKT\/mTOR Signaling in Gastric Cancer: Epigenetics and Beyond","volume":"262","author":"Fattahi","year":"2020","journal-title":"Life Sci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.critrevonc.2017.11.013","article-title":"Epigenetic Regulation of the Hedgehog and Wnt Pathways in Cancer","volume":"121","author":"Wils","year":"2018","journal-title":"Crit. Rev. Oncol.\/Hematol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrc1779","article-title":"Histone Deacetylase Inhibitors and the Promise of Epigenetic (and More) Treatments for Cancer","volume":"6","author":"Minucci","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Wu, C., Song, Q., Gao, S., and Wu, S. (2024). Targeting HDACs for Diffuse Large B-Cell Lymphoma Therapy. Sci. Rep., 14.","DOI":"10.1038\/s41598-023-50956-x"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"122639","DOI":"10.1016\/j.lfs.2024.122639","article-title":"Deciphering the Interplay of Histone Post-Translational Modifications in Cancer: Co-Targeting Histone Modulators for Precision Therapy","volume":"346","author":"Kawaf","year":"2024","journal-title":"Life Sci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2007.02.005","article-title":"Chromatin Modifications and Their Function","volume":"128","author":"Kouzarides","year":"2007","journal-title":"Cell"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nrg2905","article-title":"Charting Histone Modifications and the Functional Organization of Mammalian Genomes","volume":"12","author":"Zhou","year":"2011","journal-title":"Nat. Rev. Genet."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1073\/pnas.51.5.786","article-title":"Acetylation and Methylation of Histones and Their Possible Role in the Regulation of Rna Synthesis","volume":"51","author":"Allfrey","year":"1964","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.semcancer.2020.07.015","article-title":"Histone Modifications in Epigenetic Regulation of Cancer: Perspectives and Achieved Progress","volume":"83","author":"Neganova","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"52","DOI":"10.4103\/jcrt.jcrt_257_22","article-title":"Immunohistochemical Expression of Histone Modification Pattern in Adult Glioblastoma","volume":"20","author":"Archana","year":"2024","journal-title":"J. Cancer Res. Ther."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"216869","DOI":"10.1016\/j.canlet.2024.216869","article-title":"KAT7 Enhances the Proliferation and Metastasis of Head and Neck Squamous Carcinoma by Promoting the Acetylation Level of LDHA","volume":"590","author":"Lu","year":"2024","journal-title":"Cancer Lett."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e164990","DOI":"10.1172\/jci.insight.164990","article-title":"SET7\/9-Mediated Methylation Affects Oncogenic Functions of Histone Demethylase JMJD2A","volume":"8","author":"Gu","year":"2023","journal-title":"JCI Insight"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/bs.pmbts.2023.01.011","article-title":"Mechanistic Aspects of Reversible Methylation Modifications of Arginine and Lysine of Nuclear Histones and Their Roles in Human Colon Cancer","volume":"197","author":"Roy","year":"2023","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"5624","DOI":"10.1111\/jcmm.17589","article-title":"Modulation of the Activity of Histone Lysine Methyltransferases and Demethylases by Curcumin Analog in Leukaemia Cells","volume":"26","author":"Sawesi","year":"2022","journal-title":"J. Cell Mol. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.apsb.2024.01.006","article-title":"Blockade of the Deubiquitinating Enzyme USP48 Degrades Oncogenic HMGA2 and Inhibits Colorectal Cancer Invasion and Metastasis","volume":"14","author":"Cheng","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e001910","DOI":"10.1136\/jitc-2020-001910","article-title":"Homocitrullination of Lysine Residues Mediated by Myeloid-Derived Suppressor Cells in the Tumor Environment Is a Target for Cancer Immunotherapy","volume":"9","author":"Cook","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Liu, L., Yin, S., and Gan, W. (2023). TRAF6 Promotes PRMT5 Activity in a Ubiquitination-Dependent Manner. Cancers, 15.","DOI":"10.3390\/cancers15092501"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"113972","DOI":"10.1016\/j.celrep.2024.113972","article-title":"Hypoxia-Inducible Factor 1 Recruits FACT and RNF20\/40 to Mediate Histone Ubiquitination and Transcriptional Activation of Target Genes","volume":"43","author":"Lyu","year":"2024","journal-title":"Cell Rep."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Yang, H., Du, Y., Fei, X., Huang, S., Yimiti, M., Yang, X., Ma, J., Li, S., Tuoheniyazi, H., and Zhao, Y. (2023). SUMOylation of the Ubiquitin Ligase Component KEAP1 at K39 Upregulates NRF2 and Its Target Function in Lung Cancer Cell Proliferation. J. Biol. Chem., 299.","DOI":"10.1016\/j.jbc.2023.105215"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/35106079","article-title":"Histone Deacetylases and Cancer: Causes and Therapies","volume":"1","author":"Marks","year":"2001","journal-title":"Nat. Rev. Cancer"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"184","DOI":"10.18632\/genesandcancer.65","article-title":"Histone Acetyltransferases and Histone Deacetylases in B- and T-Cell Development, Physiology and Malignancy","volume":"6","author":"Haery","year":"2015","journal-title":"Genes. Cancer"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Sun, X.-J., Man, N., Tan, Y., Nimer, S.D., and Wang, L. (2015). The Role of Histone Acetyltransferases in Normal and Malignant Hematopoiesis. Front. Oncol., 5.","DOI":"10.3389\/fonc.2015.00108"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2174\/1566524013363537","article-title":"Histone Acetylation\/Deacetylation and Cancer: An \u201cOpen\u201d and \u201cShut\u201d Case?","volume":"1","author":"Gray","year":"2001","journal-title":"Curr. Mol. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"101815","DOI":"10.1016\/j.tranon.2023.101815","article-title":"Acetylation and Deacetylation of Histone in Adipocyte Differentiation and the Potential Significance in Cancer","volume":"39","author":"Wang","year":"2024","journal-title":"Transl. Oncol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1042\/BCJ20170314","article-title":"Co-Repressor, Co-Activator and General Transcription Factor: The Many Faces of the Sin3 Histone Deacetylase (HDAC) Complex","volume":"475","author":"Adams","year":"2018","journal-title":"Biochem. J."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.trsl.2014.05.003","article-title":"The Nucleosome Remodeling and Deacetylase (NuRD) Complex in Development and Disease","volume":"165","author":"Basta","year":"2015","journal-title":"Transl. Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"207","DOI":"10.21037\/atm-22-4371","article-title":"Regulation of Endothelial-to-Mesenchymal Transition by Histone Deacetylase 3 Posttranslational Modifications in Neointimal Hyperplasia","volume":"11","author":"Chen","year":"2023","journal-title":"Ann. Transl. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jcmgh.2022.10.015","article-title":"GLIS2 Prevents Hepatic Fibrosis by Competitively Binding HDAC3 to Inhibit Hepatic Stellate Cell Activation","volume":"15","author":"Zhang","year":"2023","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"ref_51","first-page":"172","article-title":"HDAC11 Is Related to Breast Cancer Prognosis and Inhibits Invasion and Proliferation of Breast Cancer Cells","volume":"16","author":"Zhao","year":"2023","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1006\/excr.2000.5080","article-title":"The Human Histone Deacetylase Family","volume":"262","author":"Gray","year":"2001","journal-title":"Exp. Cell Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.jsb.2016.10.008","article-title":"Human Sirtuins: Structures and Flexibility","volume":"196","author":"Sacconnay","year":"2016","journal-title":"J. Struct. Biol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1182\/bloodadvances.2023010218","article-title":"C-Terminal Binding Protein (CTBP2) Is a Novel Tumor Suppressor Targeting the MYC-IRF4 Axis in Multiple Myeloma","volume":"8","author":"Cheung","year":"2024","journal-title":"Blood Adv."},{"key":"ref_55","first-page":"324","article-title":"Histone Deacetylase Inhibitors, Intrinsic and Extrinsic Apoptotic Pathways, and Epigenetic Alterations of Histone Deacetylases (HDACs) in Hepatocellular Carcinoma","volume":"20","author":"Sanaei","year":"2021","journal-title":"Iran. J. Pharm. Res."},{"key":"ref_56","first-page":"5049","article-title":"The COOH-Terminal Region of pRb2\/P130 Binds to Histone Deacetylase 1 (HDAC1), Enhancing Transcriptional Repression of the E2F-Dependent Cyclin A Promoter1","volume":"58","author":"Stiegler","year":"1998","journal-title":"Cancer Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1006\/geno.1998.5435","article-title":"Human Histone Deacetylase 2, HDAC2 (Human RPD3), Is Localized to 6q21 by Radiation Hybrid Mapping","volume":"52","author":"Betz","year":"1998","journal-title":"Genomics"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1073\/pnas.95.6.2795","article-title":"Characterization of a Human RPD3 Ortholog,\u2009HDAC3","volume":"95","author":"Emiliani","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"25748","DOI":"10.1074\/jbc.M111871200","article-title":"Cloning and Functional Characterization of HDAC11, a Novel Member of the Human Histone Deacetylase Family","volume":"277","author":"Gao","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Seto, E., and Yoshida, M. (2014). Erasers of Histone Acetylation: The Histone Deacetylase Enzymes. Cold Spring Harb. Perspect. Biol., 6.","DOI":"10.1101\/cshperspect.a018713"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/nrm2346","article-title":"The Rpd3\/Hda1 Family of Lysine Deacetylases: From Bacteria and Yeast to Mice and Men","volume":"9","author":"Yang","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.1038\/sj.onc.1210612","article-title":"HDAC3: Taking the SMRT-N-CoRrect Road to Repression","volume":"26","author":"Karagianni","year":"2007","journal-title":"Oncogene"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1042\/bj3500199","article-title":"Cloning and Characterization of a Novel Human Histone Deacetylase, HDAC8","volume":"350","author":"Buggy","year":"2000","journal-title":"Biochem. J."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"16191","DOI":"10.1074\/jbc.M908066199","article-title":"N-Terminal Region, C-Terminal Region, Nuclear Export Signal, and Deacetylation Activity of Histone Deacetylase-3 Are Essential for the Viability of the DT40 Chicken B Cell Line","volume":"275","author":"Takami","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"9447","DOI":"10.1074\/jbc.M105993200","article-title":"Functional Domains of Histone Deacetylase-3","volume":"277","author":"Yang","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"4868","DOI":"10.1073\/pnas.96.9.4868","article-title":"Three Proteins Define a Class of Human Histone Deacetylases Related to Yeast Hda1p","volume":"96","author":"Grozinger","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Hess, L., Moos, V., Lauber, A.A., Reiter, W., Schuster, M., Hartl, N., Lackner, D., Boenke, T., Koren, A., and Guzzardo, P.M. (2022). A Toolbox for Class I HDACs Reveals Isoform Specific Roles in Gene Regulation and Protein Acetylation. PLoS Genet., 18.","DOI":"10.1371\/journal.pgen.1010376"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"H199","DOI":"10.1152\/ajpheart.00271.2016","article-title":"A Class of Their Own: Exploring the Nondeacetylase Roles of Class IIa HDACs in Cardiovascular Disease","volume":"311","author":"Wright","year":"2016","journal-title":"Am. J. Physiol.-Heart Circ. Physiol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0014-5793(01)02327-4","article-title":"Histone Deacetylase Complexes: Functional Entities or Molecular Reservoirs","volume":"494","author":"Khochbin","year":"2001","journal-title":"FEBS Lett."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1128\/MCB.01415-06","article-title":"Regulation of HDAC9 Gene Expression by MEF2 Establishes a Negative-Feedback Loop in the Transcriptional Circuitry of Muscle Differentiation","volume":"27","author":"Haberland","year":"2007","journal-title":"Mol. Cell Biol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"10572","DOI":"10.1073\/pnas.191375098","article-title":"Cloning and Characterization of a Histone Deacetylase, HDAC9","volume":"98","author":"Zhou","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1139\/o01-032","article-title":"Class II Histone Deacetylases: Structure, Function, and Regulation","volume":"79","author":"Bertos","year":"2001","journal-title":"Biochem. Cell Biol."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Curcio, A., Rocca, R., Alcaro, S., and Artese, A. (2024). The Histone Deacetylase Family: Structural Features and Application of Combined Computational Methods. Pharmaceuticals, 17.","DOI":"10.3390\/ph17050620"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s10020-021-00375-3","article-title":"Posttranslational Modification and beyond: Interplay between Histone Deacetylase 6 and Heat-Shock Protein 90","volume":"27","author":"Liu","year":"2021","journal-title":"Mol. Med."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1074\/jbc.M109861200","article-title":"Molecular Cloning and Characterization of a Novel Histone Deacetylase HDAC10","volume":"277","author":"Guardiola","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.cmet.2007.11.006","article-title":"Conserved Metabolic Regulatory Functions of Sirtuins","volume":"7","author":"Schwer","year":"2008","journal-title":"Cell Metab."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Khatun, S., Prasad Bhagat, R., Dutta, R., Datta, A., Jaiswal, A., Halder, S., Jha, T., Amin, S.A., and Gayen, S. (2024). Unraveling HDAC11: Epigenetic Orchestra in Different Diseases and Structural Insights for Inhibitor Design. Biochem. Pharmacol., 225.","DOI":"10.1016\/j.bcp.2024.116312"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1016\/j.bmcl.2017.05.004","article-title":"Stabilizing HDAC11 with SAHA to Assay Slow-Binding Benzamide Inhibitors","volume":"27","author":"Tian","year":"2017","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"ref_79","first-page":"229","article-title":"Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA A Cancer J. Clin."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A Global View of Hepatocellular Carcinoma: Trends, Risk, Prevention and Management","volume":"16","author":"Yang","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_81","first-page":"107100","article-title":"Hepatocellular Carcinoma in Patients without Cirrhosis","volume":"31","author":"Chotiprasidhi","year":"2025","journal-title":"World J. Gastroenterol."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Amin, N., Anwar, J., Sulaiman, A., Naumova, N.N., and Anwar, N. (2025). Hepatocellular Carcinoma: A Comprehensive Review. Diseases, 13.","DOI":"10.3390\/diseases13070207"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Fan, C., Kam, S., and Ramadori, P. (2021). Metabolism-Associated Epigenetic and Immunoepigenetic Reprogramming in Liver Cancer. Cancers, 13.","DOI":"10.3390\/cancers13205250"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.3346\/jkms.2015.30.10.1375","article-title":"Histone Deacetylases and Their Regulatory MicroRNAs in Hepatocarcinogenesis","volume":"30","author":"Kim","year":"2015","journal-title":"J. Korean Med. Sci."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"5300","DOI":"10.21037\/tcr-24-23","article-title":"HDAC1: A Promising Target for Cancer Treatment: Insights from a Thorough Analysis of Tumor Functions","volume":"13","author":"Xie","year":"2024","journal-title":"Transl. Cancer Res."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Freese, K., Seitz, T., Dietrich, P., Lee, S.M.L., Thasler, W.E., Bosserhoff, A., and Hellerbrand, C. (2019). Histone Deacetylase Expressions in Hepatocellular Carcinoma and Functional Effects of Histone Deacetylase Inhibitors on Liver Cancer Cells In Vitro. Cancers, 11.","DOI":"10.3390\/cancers11101587"},{"key":"ref_87","first-page":"339","article-title":"Aberrant Histone Deacetylase 1 Expression Upregulates Vimentin Expression via an NF-\u03baB-Dependent Pathway in Hepatocellular Carcinoma","volume":"18","author":"Zhou","year":"2019","journal-title":"Oncol. Lett."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1053\/j.gastro.2012.05.033","article-title":"Histone Deacetylases Activate Hepatocyte Growth Factor Signaling by Repressing MicroRNA-449 in Hepatocellular Carcinoma Cells","volume":"143","author":"Buurman","year":"2012","journal-title":"Gastroenterology"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.3892\/or.2015.4263","article-title":"HDAC1 and HDAC2 Independently Predict Mortality in Hepatocellular Carcinoma by a Competing Risk Regression Model in a Southeast Asian Population","volume":"34","author":"Ler","year":"2015","journal-title":"Oncol. Rep."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.jhep.2012.01.009","article-title":"Combination Therapy for Hepatocellular Carcinoma: Additive Preclinical Efficacy of the HDAC Inhibitor Panobinostat with Sorafenib","volume":"56","author":"Lachenmayer","year":"2012","journal-title":"J. Hepatol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"11523","DOI":"10.1007\/s13277-014-2358-2","article-title":"Down-Regulation of HDAC5 Inhibits Growth of Human Hepatocellular Carcinoma by Induction of Apoptosis and Cell Cycle Arrest","volume":"35","author":"Fan","year":"2014","journal-title":"Tumor Biol."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Ye, M., Fang, Z., Gu, H., Song, R., Ye, J., Li, H., Wu, Z., Zhou, S., Li, P., and Cai, X. (2017). Histone Deacetylase 5 Promotes the Migration and Invasion of Hepatocellular Carcinoma via Increasing the Transcription of Hypoxia-Inducible Factor-1\u03b1 under Hypoxia Condition. Tumour Biol., 39.","DOI":"10.1177\/1010428317705034"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Xu, X., Ding, P., Shi, L., Wu, G., and Ma, X. (2022). LukS-PV Inhibits Hepatocellular Carcinoma Cells Migration by Downregulating HDAC6 Expression. BMC Cancer, 22.","DOI":"10.1186\/s12885-022-09680-4"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1758835920913432","DOI":"10.1177\/1758835920913432","article-title":"AR420626, a Selective Agonist of GPR41\/FFA3, Suppresses Growth of Hepatocellular Carcinoma Cells by Inducing Apoptosis via HDAC Inhibition","volume":"12","author":"Mikami","year":"2020","journal-title":"Ther. Adv. Med. Oncol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.1007\/s10620-013-2867-7","article-title":"The Up-Regulation of Histone Deacetylase 8 Promotes Proliferation and Inhibits Apoptosis in Hepatocellular Carcinoma","volume":"58","author":"Wu","year":"2013","journal-title":"Dig. Dis. Sci."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"eaaz6804","DOI":"10.1126\/scitranslmed.aaz6804","article-title":"A Selective HDAC8 Inhibitor Potentiates Antitumor Immunity and Efficacy of Immune Checkpoint Blockade in Hepatocellular Carcinoma","volume":"13","author":"Yang","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.21037\/tcr-20-3415","article-title":"PD-L1 Combined with HDAC9 Is a Useful Prognostic Predictor in Hepatocellular Carcinoma","volume":"10","author":"Yang","year":"2021","journal-title":"Transl. Cancer Res."},{"key":"ref_98","first-page":"983","article-title":"Inhibition of Histone Deacetylase 11 Promotes Human Liver Cancer Cell Apoptosis","volume":"11","author":"Gong","year":"2019","journal-title":"Am. J. Transl. Res."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1056\/NEJMra1805035","article-title":"Epigenetic Therapies for Cancer","volume":"383","author":"Bates","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"116129","DOI":"10.1016\/j.ejmech.2024.116129","article-title":"HDAC-Targeting Epigenetic Modulators for Cancer Immunotherapy","volume":"265","author":"Cheng","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"718","DOI":"10.2174\/1389450123666221003094908","article-title":"Therapeutic Potential of HDAC Inhibitors in the Treatment of Cardiac Diseases: A Short Review","volume":"24","author":"Tiwari","year":"2023","journal-title":"Curr. Drug Targets"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.2174\/0929867329666220922105615","article-title":"Multi-Targeted HDAC Inhibitors as Anticancer Agents: Current Status and Future Prospective","volume":"30","author":"Patel","year":"2023","journal-title":"Curr. Med. Chem."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"745","DOI":"10.4155\/fmc-2021-0276","article-title":"New Kinase and HDAC Hybrid Inhibitors: Recent Advances and Perspectives","volume":"14","author":"Waitman","year":"2022","journal-title":"Future Med. Chem."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"115938","DOI":"10.1016\/j.ejmech.2023.115938","article-title":"Dual Inhibitors of HDAC and Other Epigenetic Regulators: A Novel Strategy for Cancer Treatment","volume":"263","author":"Shirbhate","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Karagianni, F., Piperi, C., Valero-Diaz, S., Amato, C., Vaque, J.P., Casar, B., and Papadavid, E. (2024). Combination of JAKi and HDACi Exerts Antiangiogenic Potential in Cutaneous T-Cell Lymphoma. Cancers, 16.","DOI":"10.3390\/cancers16183176"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41420-024-01895-7","article-title":"Dual Inhibitors of DNMT and HDAC Induce Viral Mimicry to Induce Antitumour Immunity in Breast Cancer","volume":"10","author":"Huang","year":"2024","journal-title":"Cell Death Discov."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/17474124.2019.1568870","article-title":"Unmasking the Pathological and Therapeutic Potential of Histone Deacetylases for Liver Cancer","volume":"13","author":"Zhao","year":"2019","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Chang, Y., Lee, Y.B., Cho, E.J., Lee, J.-H., Yu, S.J., Kim, Y.J., and Yoon, J.-H. (2020). CKD-5, a Novel Pan-Histone Deacetylase Inhibitor, Synergistically Enhances the Efficacy of Sorafenib for Hepatocellular Carcinoma. BMC Cancer, 20.","DOI":"10.1186\/s12885-020-07471-3"},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Streubel, G., Schrepfer, S., Kallus, H., Parnitzke, U., Wulff, T., Hermann, F., Borgmann, M., and Hamm, S. (2021). Histone Deacetylase Inhibitor Resminostat in Combination with Sorafenib Counteracts Platelet-Mediated pro-Tumoral Effects in Hepatocellular Carcinoma. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-88983-1"},{"key":"ref_110","first-page":"3155","article-title":"A Novel Liver Cancer-Selective Histone Deacetylase Inhibitor Is Effective Against Hepatocellular Carcinoma and Induces Durable Responses with Immunotherapy","volume":"7","author":"Wu","year":"2024","journal-title":"bioRxiv"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1136\/gutjnl-2024-332281","article-title":"Pharmacological Activation of STAT1-GSDME Pyroptotic Circuitry Reinforces Epigenetic Immunotherapy for Hepatocellular Carcinoma","volume":"74","author":"Tu","year":"2024","journal-title":"Gut"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"216063","DOI":"10.1016\/j.canlet.2023.216063","article-title":"Synergistic Efficacy of Telomerase-Specific Oncolytic Adenoviral Therapy and Histone Deacetylase Inhibition in Human Hepatocellular Carcinoma","volume":"556","author":"Lin","year":"2023","journal-title":"Cancer Lett."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.4251\/wjgo.v16.i7.2867","article-title":"Oncolytic Virotherapy for Hepatocellular Carcinoma: A Potent Immunotherapeutic Landscape","volume":"16","author":"Xiao","year":"2024","journal-title":"World J. Gastrointest. Oncol."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Lai, S.-Y., Zhu, X.-J., Sun, W.-D., Bi, S.-Z., Zhang, C.-Y., Liu, A., and Li, J.-H. (2025). Nicotinamide N-Methyltransferase (NNMT) and Liver Cancer: From Metabolic Networks to Therapeutic Targets. Biomolecules, 15.","DOI":"10.3390\/biom15050719"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/nchembio.1204","article-title":"NNMT Promotes Epigenetic Remodeling in Cancer by Creating a Metabolic Methylation Sink","volume":"9","author":"Ulanovskaya","year":"2013","journal-title":"Nat. Chem. Biol."},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Shen, C., Li, M., Duan, Y., Jiang, X., Hou, X., Xue, F., Zhang, Y., and Luo, Y. (2023). HDAC Inhibitors Enhance the Anti-Tumor Effect of Immunotherapies in Hepatocellular Carcinoma. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1170207"},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Eckschlager, T., Plch, J., Stiborova, M., and Hrabeta, J. (2017). Histone Deacetylase Inhibitors as Anticancer Drugs. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18071414"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jhep.2016.02.043","article-title":"Resminostat plus Sorafenib as Second-Line Therapy of Advanced Hepatocellular Carcinoma\u2014The SHELTER Study","volume":"65","author":"Bitzer","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.bbrc.2016.04.147","article-title":"Activation of mPTP-Dependent Mitochondrial Apoptosis Pathway by a Novel Pan HDAC Inhibitor Resminostat in Hepatocellular Carcinoma Cells","volume":"477","author":"Fu","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"110367","DOI":"10.18632\/oncotarget.22775","article-title":"Resminostat Induces Changes in Epithelial Plasticity of Hepatocellular Carcinoma Cells and Sensitizes Them to Sorafenib-Induced Apoptosis","volume":"8","author":"Soukupova","year":"2017","journal-title":"Oncotarget"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.7150\/ijbs.93375","article-title":"HDAC Inhibition Sensitize Hepatocellular Carcinoma to Lenvatinib via Suppressing AKT Activation","volume":"20","author":"Yan","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"5935","DOI":"10.3390\/cimb45070375","article-title":"The Synergistic Antitumor Effect of Decitabine and Vorinostat Combination on HepG2 Human Hepatocellular Carcinoma Cell Line via Epigenetic Modulation of Autophagy\u2013Apoptosis Molecular Crosstalk","volume":"45","author":"Salama","year":"2023","journal-title":"Curr. Issues Mol. Biol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"5038","DOI":"10.3748\/wjg.v29.i34.5038","article-title":"Suberoylanilide Hydroxamic Acid Upregulates Reticulophagy Receptor Expression and Promotes Cell Death in Hepatocellular Carcinoma Cells","volume":"29","author":"Li","year":"2023","journal-title":"World J. Gastroenterol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/cac2.12595","article-title":"Targeting N4-Acetylcytidine Suppresses Hepatocellular Carcinoma Progression by Repressing eEF2-Mediated HMGB2 mRNA Translation","volume":"44","author":"Liu","year":"2024","journal-title":"Cancer Commun."},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Choi, C., Lee, G.H., Son, A., Yoo, G.S., Yu, J.I., and Park, H.C. (2021). Downregulation of Mcl-1 by Panobinostat Potentiates Proton Beam Therapy in Hepatocellular Carcinoma Cells. Cells, 10.","DOI":"10.3390\/cells10030554"},{"key":"ref_126","first-page":"285","article-title":"The Pan-Deacetylase Inhibitor Panobinostat Inhibits Growth of Hepatocellular Carcinoma Models by Alternative Pathways of Apoptosis","volume":"32","author":"Neureiter","year":"2010","journal-title":"Cell Oncol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.bcp.2016.12.008","article-title":"Romidepsin Induces G2\/M Phase Arrest via Erk\/cdc25C\/Cdc2\/cyclinB Pathway and Apoptosis Induction through JNK\/c-Jun\/Caspase3 Pathway in Hepatocellular Carcinoma Cells","volume":"127","author":"Sun","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"5575","DOI":"10.2147\/OTT.S250233","article-title":"HDAC1\/2 Inhibitor Romidepsin Suppresses DEN-Induced Hepatocellular Carcinogenesis in Mice","volume":"13","author":"Afaloniati","year":"2020","journal-title":"Onco Targets Ther."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"5209","DOI":"10.1038\/s41467-024-49573-7","article-title":"Acetylation-Dependent Regulation of Core Spliceosome Modulates Hepatocellular Carcinoma Cassette Exons and Sensitivity to PARP Inhibitors","volume":"15","author":"Sun","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_130","first-page":"1093","article-title":"Synergistic Activity of Histone Deacetylase and Proteasome Inhibition Against Pancreatic and Hepatocellular Cancer Cell Lines","volume":"31","author":"Spratlin","year":"2011","journal-title":"Anticancer. Res."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10637-009-9219-7","article-title":"The Preclinical Activity of the Histone Deacetylase Inhibitor PXD101 (Belinostat) in Hepatocellular Carcinoma Cell Lines","volume":"28","author":"Ma","year":"2010","journal-title":"Investig. New Drugs"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00262-018-2283-0","article-title":"Enhanced Anti-Tumor Efficacy of Checkpoint Inhibitors in Combination with the Histone Deacetylase Inhibitor Belinostat in a Murine Hepatocellular Carcinoma Model","volume":"68","author":"Llopiz","year":"2018","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1080\/10428194.2018.1492122","article-title":"Resminostat in Patients with Relapsed or Refractory Hodgkin Lymphoma: Results of the Phase II SAPHIRE Study","volume":"60","author":"Walewski","year":"2019","journal-title":"Leuk. Lymphoma"},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Karagianni, F., Piperi, C., Mpakou, V., Spathis, A., Foukas, P.G., Dalamaga, M., Pappa, V., and Papadavid, E. (2021). Ruxolitinib with Resminostat Exert Synergistic Antitumor Effects in Cutaneous T-Cell Lymphoma. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0248298"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10637-018-0634-5","article-title":"Phase I Study of Resminostat, an HDAC Inhibitor, Combined with S-1 in Patients with Pre-Treated Biliary Tract or Pancreatic Cancer","volume":"37","author":"Ikeda","year":"2019","journal-title":"Investig. New Drugs"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"5494","DOI":"10.1158\/1078-0432.CCR-13-0735","article-title":"First-in-Human, Pharmacokinetic and Pharmacodynamic Phase I Study of Resminostat, an Oral Histone Deacetylase Inhibitor, in Patients with Advanced Solid Tumors","volume":"19","author":"Brunetto","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1007\/s10637-018-0658-x","article-title":"Phase I\/II Study of First-Line Combination Therapy with Sorafenib plus Resminostat, an Oral HDAC Inhibitor, versus Sorafenib Monotherapy for Advanced Hepatocellular Carcinoma in East Asian Patients","volume":"36","author":"Tak","year":"2018","journal-title":"Investig. New Drugs"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.bbrc.2016.06.060","article-title":"mTOR Inhibition Sensitizes Human Hepatocellular Carcinoma Cells to Resminostat","volume":"477","author":"Peng","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1002\/cncr.34974","article-title":"Recent Histone Deacetylase Inhibitors in Cancer Therapy","volume":"129","author":"Parveen","year":"2023","journal-title":"Cancer"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.31557\/APJCP.2021.22.7.2089","article-title":"Effect of Decitabine (5-Aza-2\u2032-Deoxycytidine, 5-Aza-CdR) in Comparison with Vorinostat (Suberoylanilide Hydroxamic Acid, SAHA) on DNMT1, DNMT3a and DNMT3b, HDAC 1-3, SOCS 1, SOCS 3, JAK2, and STAT3 Gene Expression in Hepatocellular Carcinoma HLE and LCL-PI 11 Cell Lines","volume":"22","author":"Sanaei","year":"2021","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_141","first-page":"7131802","article-title":"Efficacy of Panobinostat for the Treatment of Multiple Myeloma","volume":"2020","author":"Kanellias","year":"2020","journal-title":"J. Oncol."},{"key":"ref_142","first-page":"25","article-title":"Chapter 3\u2014Histone Deacetylase Inhibitors (HDACi), the Ongoing Epigenetic Agents to Enhance Chemotherapy Sensitization","volume":"Volume 15","author":"Wu","year":"2021","journal-title":"Epigenetic Regulation in Overcoming Chemoresistance"},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Liu, Y.-F., Chiang, Y., Hsu, F.-M., Tsai, C.-L., and Cheng, J.C.-H. (2022). Radiosensitization Effect by HDAC Inhibition Improves NKG2D-Dependent Natural Killer Cytotoxicity in Hepatocellular Carcinoma. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.1009089"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"28998","DOI":"10.18632\/oncotarget.8585","article-title":"Autophagy-Related Cell Death by Pan-Histone Deacetylase Inhibition in Liver Cancer","volume":"7","author":"Waldegger","year":"2016","journal-title":"Oncotarget"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/mc.22122","article-title":"The Pan-Deacetylase Inhibitor Panobinostat Suppresses the Expression of Oncogenic miRNAs in Hepatocellular Carcinoma Cell Lines","volume":"54","author":"Henrici","year":"2015","journal-title":"Mol. Carcinog."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1111\/bcp.14889","article-title":"Recent Developments of HDAC Inhibitors: Emerging Indications and Novel Molecules","volume":"87","author":"Bondarev","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"e12447","DOI":"10.1111\/cpr.12447","article-title":"Pharmacological or Transcriptional Inhibition of Both HDAC1 and 2 Leads to Cell Cycle Blockage and Apoptosis via p21Waf1\/Cip1 and p19INK4d Upregulation in Hepatocellular Carcinoma","volume":"51","author":"Zhou","year":"2018","journal-title":"Cell Prolif."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s11033-020-06089-9","article-title":"Romidepsin Hepatocellular Carcinoma Suppression in Mice Is Associated with Deregulated Gene Expression of Bone Morphogenetic Protein and Notch Signaling Pathway Components","volume":"48","author":"Afaloniati","year":"2021","journal-title":"Mol. Biol. Rep."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.clinre.2020.01.003","article-title":"In Vitro High-Throughput Drug Sensitivity Screening with Patient-Derived Primary Cells as a Guide for Clinical Practice in Hepatocellular Carcinoma\u2014A Retrospective Evaluation","volume":"44","author":"Li","year":"2020","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s12672-025-02307-7","article-title":"Plasma Protein Levels and Hepatocellular Carcinoma: A Mendelian Randomization Study with Drug Screening Implications","volume":"16","author":"Xie","year":"2025","journal-title":"Discov. Oncol."},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"Kim, N., and Yang, C. (2024). Butyrate as a Potential Modulator in Gynecological Disease Progression. Nutrients, 16.","DOI":"10.3390\/nu16234196"},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Merarchi, M., Sethi, G., Shanmugam, M.K., Fan, L., Arfuso, F., and Ahn, K.S. (2019). Role of Natural Products in Modulating Histone Deacetylases in Cancer. Molecules, 24.","DOI":"10.3390\/molecules24061047"},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Singh, A.K., Bishayee, A., and Pandey, A.K. (2018). Targeting Histone Deacetylases with Natural and Synthetic Agents: An Emerging Anticancer Strategy. Nutrients, 10.","DOI":"10.3390\/nu10060731"},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Choi, S.-W., and Friso, S. (2009). Nutrients and Epigenetics, CRC Press.","DOI":"10.1201\/9781420063561"},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Fusco, W., Lorenzo, M.B., Cintoni, M., Porcari, S., Rinninella, E., Kaitsas, F., Lener, E., Mele, M.C., Gasbarrini, A., and Collado, M.C. (2023). Short-Chain Fatty-Acid-Producing Bacteria: Key Components of the Human Gut Microbiota. Nutrients, 15.","DOI":"10.3390\/nu15092211"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/hep.32449","article-title":"Gut Microbiota\u2013Derived Short-chain Fatty Acids Regulate Group 3 Innate Lymphoid Cells in HCC","volume":"77","author":"Hu","year":"2023","journal-title":"Hepatology"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"31342","DOI":"10.18632\/oncotarget.25809","article-title":"A Short-Chain Fatty Acid, Propionate, Enhances the Cytotoxic Effect of Cisplatin by Modulating GPR41 Signaling Pathways in HepG2 Cells","volume":"9","author":"Kobayashi","year":"2018","journal-title":"Oncotarget"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"5823","DOI":"10.1007\/s00432-022-04544-7","article-title":"Bacterial Metabolite Butyrate in Modulating Sorafenib-Targeted microRNAs to Curtail Its Resistance in Hepatocellular Carcinoma","volume":"149","author":"Kumar","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"2326241","DOI":"10.1080\/27694127.2024.2326241","article-title":"Simultaneous Activation and Blockade of Autophagy to Fight Hepatocellular Carcinoma","volume":"3","author":"Shalhoub","year":"2024","journal-title":"Autophagy Rep."},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Sanaei, M., Kavoosi, F., and Safari, M. (2023). Effect of 5\u2032-Fluoro-2\u2032-Deoxycytidine and Sodium Butyrate on the Gene Expression of the Intrinsic Apoptotic Pathway, P21, P27, and P53 Genes Expression, Cell Viability, and Apoptosis in Human Hepatocellular Carcinoma Cell Lines. Adv. Biomed. Res., 12.","DOI":"10.4103\/abr.abr_211_21"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/cbf.3212","article-title":"The Expression of Tumor Suppressor Gene Cyld Is Upregulated by Histone Deacetylace Inhibitors in Human Hepatocellular Carcinoma Cell Lines","volume":"34","author":"Kotantaki","year":"2016","journal-title":"Cell Biochem. Funct."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.biocel.2019.05.014","article-title":"Histone Deacetylase Inhibitors Promote ATP2A3 Gene Expression in Hepatocellular Carcinoma Cells: P300 as a Transcriptional Regulator","volume":"113","year":"2019","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41551-024-01190-x","article-title":"A Serine-Conjugated Butyrate Prodrug with High Oral Bioavailability Suppresses Autoimmune Arthritis and Neuroinflammation in Mice","volume":"8","author":"Cao","year":"2024","journal-title":"Nat. Biomed. Eng."},{"key":"ref_164","doi-asserted-by":"crossref","unstructured":"Chen, J., Zhao, K.-N., and Vitetta, L. (2019). Effects of Intestinal Microbial\u2013Elaborated Butyrate on Oncogenic Signaling Pathways. Nutrients, 11.","DOI":"10.3390\/nu11051026"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.omto.2020.08.017","article-title":"Valeric Acid Suppresses Liver Cancer Development by Acting as a Novel HDAC Inhibitor","volume":"19","author":"Han","year":"2020","journal-title":"Mol. Ther. Oncolytics"},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Mayorga-Ramos, A., Barba-Ostria, C., Simancas-Racines, D., and Guam\u00e1n, L.P. (2022). Protective Role of Butyrate in Obesity and Diabetes: New Insights. Front. Nutr., 9.","DOI":"10.3389\/fnut.2022.1067647"},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Longtine, A.G., Greenberg, N.T., Gonzalez, A., Lindquist, A., VanDongen, N.S., Mahoney, S.A., Rahman, G., Clayton, Z.S., Ziemba, B.P., and Ludwig, K.R. (2024). Oral Supplementation with the Short-Chain Fatty Acid Acetate Ameliorates Age-Related Arterial Dysfunction in Mice. Aging Biol., 2.","DOI":"10.59368\/agingbio.20240033"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.alit.2017.06.008","article-title":"Gut Microbiome, Metabolome, and Allergic Diseases","volume":"66","author":"Hirata","year":"2017","journal-title":"Allergol. Int."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.jhep.2015.04.018","article-title":"Curcumin Effectively Inhibits Oncogenic NF-kB Signaling and Restrains Stemness Features in Liver Cancer","volume":"63","author":"Marquardt","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.31557\/APJCP.2020.21.4.1045","article-title":"Effect of Curcumin in Comparison with Trichostatin A on the Reactivation of Estrogen Receptor Alpha Gene Expression, Cell Growth Inhibition and Apoptosis Induction in Hepatocellular Carcinoma Hepa 1-6 Cell lLine","volume":"21","author":"Sanaei","year":"2020","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1021\/mp700113r","article-title":"Bioavailability of Curcumin: Problems and Promises","volume":"4","author":"Anand","year":"2007","journal-title":"Mol. Pharm."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"5747","DOI":"10.1002\/jsfa.11372","article-title":"Curcumin, the Active Substance of Turmeric: Its Effects on Health and Ways to Improve Its Bioavailability","volume":"101","author":"Swelum","year":"2021","journal-title":"J. Sci. Food Agric."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"111047","DOI":"10.1016\/j.fct.2019.111047","article-title":"Transcriptome and DNA Methylation Changes Modulated by Sulforaphane Induce Cell Cycle Arrest, Apoptosis, DNA Damage, and Suppression of Proliferation in Human Liver Cancer Cells","volume":"136","author":"Machado","year":"2020","journal-title":"Food Chem. Toxicol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.joim.2023.08.002","article-title":"Sulforaphane, an NRF2 Agonist, Alleviates Ferroptosis in Acute Liver Failure by Regulating HDAC6 Activity","volume":"21","author":"Zhang","year":"2023","journal-title":"J. Integr. Med."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1080\/14737140.2024.2438951","article-title":"NRF2\/KEAP1 Signaling Inhibitors in Gynecologic Cancers","volume":"24","author":"Fantone","year":"2024","journal-title":"Expert Rev. Anticancer. Ther."},{"key":"ref_176","doi-asserted-by":"crossref","unstructured":"Schiavoni, V., Emanuelli, M., Milanese, G., Galosi, A.B., Pompei, V., Salvolini, E., and Campagna, R. (2024). Nrf2 Signaling in Renal Cell Carcinoma: A Potential Candidate for the Development of Novel Therapeutic Strategies. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252413239"},{"key":"ref_177","doi-asserted-by":"crossref","unstructured":"Tossetta, G., Fantone, S., Togni, L., Santarelli, A., Olivieri, F., Marzioni, D., and Rippo, M.R. (2024). Modulation of NRF2\/KEAP1 Signaling by Phytotherapeutics in Periodontitis. Antioxidants, 13.","DOI":"10.3390\/antiox13101270"},{"key":"ref_178","doi-asserted-by":"crossref","unstructured":"Tossetta, G., Fantone, S., Piani, F., Crescimanno, C., Ciavattini, A., Giannubilo, S.R., and Marzioni, D. (2023). Modulation of NRF2\/KEAP1 Signaling in Preeclampsia. Cells, 12.","DOI":"10.3390\/cells12111545"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s10068-023-01434-7","article-title":"Plant Sources, Extraction Techniques, Analytical Methods, Bioactivity, and Bioavailability of Sulforaphane: A Review","volume":"33","author":"Men","year":"2023","journal-title":"Food Sci. Biotechnol."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"e1700980","DOI":"10.1002\/mnfr.201700980","article-title":"Supplementation of the Diet by Exogenous Myrosinase via Mustard Seeds to Increase the Bioavailability of Sulforaphane in Healthy Human Subjects after the Consumption of Cooked Broccoli","volume":"62","author":"Okunade","year":"2018","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_181","doi-asserted-by":"crossref","unstructured":"Yan, L., and Yan, Y. (2023). Therapeutic Potential of Sulforaphane in Liver Diseases: A Review. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1256029"},{"key":"ref_182","doi-asserted-by":"crossref","unstructured":"Venturelli, S., Berger, A., B\u00f6cker, A., Busch, C., Weiland, T., Noor, S., Leischner, C., Schleicher, S., Mayer, M., and Weiss, T.S. (2013). Resveratrol as a Pan-HDAC Inhibitor Alters the Acetylation Status of Jistone Proteins in Human-Derived Hepatoblastoma Cells. PLoS ONE, 8.","DOI":"10.1371\/annotation\/5b9a8614-1009-40ca-b90b-db817fe445c9"},{"key":"ref_183","doi-asserted-by":"crossref","unstructured":"Nowrasteh, G., Zand, A., Raposa, L.B., Szab\u00f3, L., Tomesz, A., Moln\u00e1r, R., Kiss, I., Ors\u00f3s, Z., Gerencs\u00e9r, G., and Gy\u00f6ngyi, Z. (2023). Fruit Extract, Rich in Polyphenols and Flavonoids, Modifies the Expression of DNMT and HDAC Genes Involved in Epigenetic Processes. Nutrients, 15.","DOI":"10.3390\/nu15081867"},{"key":"ref_184","first-page":"13","article-title":"Health Benefits of Resveratrol Administration","volume":"66","author":"Galiniak","year":"2019","journal-title":"Acta Biochim. Pol."},{"key":"ref_185","doi-asserted-by":"crossref","unstructured":"de Vries, K., Strydom, M., and Steenkamp, V. (2021). A Brief Updated Review of Advances to Enhance Resveratrol\u2019s Bioavailability. Molecules, 26.","DOI":"10.3390\/molecules26144367"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/ptr.8379","article-title":"Resveratrol Bioavailability After Oral Administration: A Meta-Analysis of Clinical Trial Data","volume":"39","author":"Szymkowiak","year":"2025","journal-title":"Phytother. Res."},{"key":"ref_187","first-page":"3445","article-title":"Genistein and Trichostatin A Induction of Estrogen Receptor Alpha Gene Expression, Apoptosis and Cell Growth Inhibition in Hepatocellular Carcinoma HepG 2 Cells","volume":"18","author":"Sanaei","year":"2017","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"141","DOI":"10.14218\/JCTH.2018.00002","article-title":"Effect of Genistein in Comparison with Trichostatin A on Reactivation of DNMTs Genes in Hepatocellular Carcinoma","volume":"6","author":"Sanaei","year":"2018","journal-title":"J. Clin. Transl. Hepatol."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.31557\/APJCP.2019.20.4.1119","article-title":"Effect of DNA Methyltransferase in Comparison to and in Combination with Histone Deacetylase Inhibitors on Hepatocellular Carcinoma HepG2 Cell Line","volume":"20","author":"Sanaei","year":"2019","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/13510002.2022.2031515","article-title":"Chemopreventive and Hepatoprotective Effects of Genistein via Inhibition of Oxidative Stress and the Versican\/PDGF\/PKC Signaling Pathway in Experimentally Induced Hepatocellular Carcinoma in Rats by Thioacetamide","volume":"27","author":"Khodir","year":"2022","journal-title":"Redox Rep."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"3268136","DOI":"10.1155\/2021\/3268136","article-title":"Genistein: An Integrative Overview of Its Mode of Action, Pharmacological Properties, and Health Benefits","volume":"2021","author":"Quispe","year":"2021","journal-title":"Oxid. Med. Cell Longev."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"1362S","DOI":"10.1093\/jn\/131.4.1362S","article-title":"Bioavailability of Pure Isoflavones in Healthy Humans and Analysis of Commercial Soy Isoflavone Supplements","volume":"131","author":"Setchell","year":"2001","journal-title":"J. Nutr."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"9286","DOI":"10.1038\/s41467-024-53295-1","article-title":"Epigenetic Memory of Radiotherapy in Dermal Fibroblasts Impairs Wound Repair Capacity in Cancer Survivors","volume":"15","author":"Bian","year":"2024","journal-title":"Nat. Commun."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/14\/17\/1337\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:35:16Z","timestamp":1760034916000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/14\/17\/1337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,29]]},"references-count":193,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["cells14171337"],"URL":"https:\/\/doi.org\/10.3390\/cells14171337","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,29]]}}}